NIH Launches Trial of Hydroxychloroquine, Azithromycin for COVID-19
FRIDAY, May 15, 2020 -- The National Institute of Allergy and Infectious Diseases (NIAID) announced it is sponsoring a phase 2b clinical trial to evaluate the efficacy and safety of hydroxychloroquine and azithromycin in preventing hospitalization...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Allergy | Allergy & Immunology | Azithromycin | Clinical Trials | COVID-19 | Hydroxychloroquine | Infectious Diseases | Pharmaceuticals | Zithromax